Navigation Links
Ovalum Ltd. Received Clearance to Market the CiTop™ Product-Line in Israel
Date:7/10/2008

Following FDA clearance and CE approval, revolutionary CiTop™ product-line is now available in Israel. Ovalum Ltd., a privately held Israeli medical device company, has announced today the clearance to market of its unique CiTop™ product-line in Israel.

Rehovot, Israel (PRWEB) July 10, 2008 -- Ovalum Ltd., a privately held Israeli medical device company, has announced today the clearance to market of its unique CiTop™ product-line in Israel. These products are indicated for traversing arterial obstructions, including chronic total occlusions, to allow blood flow through the vasculature.

Dr. Alexander Belenky, Head of Interventional Radiology Unit at Rabin Medical Center and chief Radiologist at Assuta Tel-Aviv Medical Center says: "This unique technology greatly assists in rescuing limbs which could not be treated by any other means. Opening an occluded artery is a must for saving the limb from amputation. The CiTop(tm) Guidewire System is crossing these occlusions in tremendous ease even in the most complicated cases".

According to Barry T. Katzen, MD, FACR, FACC, a member of Ovalum Ltd. Advisory Board and medical director of Baptist Cardiac and Vascular Institute in Miami, "Saving limbs is dependent on successful recanalization of total occlusions, frequently in long segments. This device is a simple and effective method in the hands of the physician to improve results in the treatment of total occlusions".

Chronic Total Occlusion (CTO) is one of the main challenges that Interventional Cardiologists and Radiologists are facing today. Ovalum's CTO solution, the CiTop™ Guidewire technology enables the minimally invasive intervention specialists to cross over the arterial blockage in a controllable and reproducible way. The system is made of a highly flexible guidewire body and a distal tip consisting of a working element with dilating capabilities to facilitate wire cross-over. The CiTop™ product-line also includes the 0.014" CoBra™ CTO Guidewire and the TraVerse™ Micro-catheter.

About Ovalum

Ovalum Ltd. was founded in March 2005 by Noam Shamay and Eitan Finkelstein. Located in Rabin Science Park Rehovot, Israel. OVALUM Ltd. develops, manufactures and markets breakthrough products for the minimally invasive cardiology and interventional radiology markets designed specifically for the most challenging arterial procedures

Ovalum Ltd. investors: Ziegler Meditech equity Partners LP and Smithfield Fiduciary LLC, represented by Eitan Machover (Director) and Pontifax LP represented by Tomer Kariv (Director).

CiTop™, CoBra™, TraVerse™ are all trademarks of Ovalum Ltd.

###


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related biology technology :

1. Ovalum Ltd. Announces Sales Launch of CiTop™ Product-Line in Europe
2. Pharmacyclics Announces It Received Nasdaq Notice of Compliance
3. WorldHeart Announces Delisting Appeal Received and Will be Considered at Hearing July 10, 2008
4. Signalife Appoints Lee Ehrlichman as Company Director and Operations Director; Additional Notice Received From Amex Regarding Sharholders Equity Deficiency
5. Pharmacyclics Announces It Received Nasdaq Notification
6. BioDuro & The National Center for Safety Evaluation of Drugs Received Full AAALAC Accreditation
7. Sirnaomics Received Multiple Government Fundings For Its Multi-Targeted siRNA Therapeutics Programs
8. Agendia BV Announces That its Chief Research Officer Laura van t Veer has Received a 2007 Breast Cancer Research Foundation Award
9. YM BIOSCIENCES ANNOUNCES FDA LIFTS CLINICAL HOLD ON AEROLEF(R) AND CLEARANCE OF A PHASE II CLINICAL TRIAL
10. MEDRAD Receives FDA 510(k) Clearance for FDG Infusion System
11. Collagen Matrix, Inc. Receives FDA 510(k) Clearance for TenoMend(TM) Collagen Tendon Wrap for the Management and Protection of Tendon Injuries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , ... October 11, 2017 , ... ... (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer ... treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and bind ...
(Date:10/10/2017)... Oct. 10, 2017 International research firm Parks Associates ... speak at the TMA 2017 Annual Meeting , October 11 in ... the residential home security market and how smart safety and security products ... Parks Associates: Smart ... "The residential security market ...
(Date:10/9/2017)... (PRWEB) , ... October 09, 2017 , ... The award-winning ... to broadcast first quarter 2018. American Farmer airs Tuesdays at 8:30aET on RFD-TV. ... is faced with the challenge of how to continue to feed a growing nation. ...
(Date:10/7/2017)... WA (PRWEB) , ... October ... ... industry leader in Hi-C-based genomic technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution ... ProxiMeta Hi-C kit and accompanying cloud-based bioinformatics software to perform Hi-C metagenome ...
Breaking Biology Technology:
(Date:5/6/2017)... , May 5, 2017 ... just announced a new breakthrough in biometric authentication ... exploits quantum mechanical properties to perform biometric authentication. These ... smart semiconductor material created by Ram Group and ... finance, entertainment, transportation, supply chains and security. Ram ...
(Date:4/18/2017)... -- Socionext Inc., a global expert in SoC-based imaging and computing solutions, ... which features the company,s hybrid codec technology. A demonstration utilizing TeraFaces ... will be showcased during the upcoming Medtec Japan at Tokyo Big ... Las Vegas Convention Center April 24-27. ... Click here for an image of ...
(Date:4/13/2017)... PUNE, India , April 13, 2017 According ... Identity Proofing, Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication ... by MarketsandMarkets™, the IAM Market is expected to grow from USD 14.30 ... Annual Growth Rate (CAGR) of 17.3%. ... ...
Breaking Biology News(10 mins):